We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+0.01%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.84B
AUM Growth
-$132M
Cap. Flow
-$56M
Cap. Flow %
-3.04%
Top 10 Hldgs %
90.16%
Holding
43
New
1
Increased
1
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$46.4M
2
WGS icon
GeneDx Holdings
WGS
+$767K

Top Sells

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$51.8M
2
RVMD icon
Revolution Medicines
RVMD
+$45.8M
3
ILMN icon
Illumina
ILMN
+$5.58M
4
BHIL
Benson Hill, Inc.
BHIL
+$6

Sector Composition

Rank Sector Weight
1 Technology 64.74%
2 Healthcare 30.94%
3 Industrials 4.15%
4 Consumer Staples 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRNS
26
Barinthus Biotherapeutics
BRNS
$24.6M
$1.8M 0.1%
1,513,644
– –
TNYA icon
27
Tenaya Therapeutics
TNYA
$167M
$1.77M 0.1%
915,705
– –
GUTS icon
28
Fractyl Health
GUTS
$127M
$1.68M 0.09%
662,584
– –
EXAS
29
DELISTED
Exact Sciences
EXAS
$1.58M 0.09%
23,205
– –
KRON
30
DELISTED
Kronos Bio
KRON
$1.44M 0.08%
1,438,232
– –
TSHA icon
31
Taysha Gene Therapies
TSHA
$1.59B
$1.29M 0.07%
640,882
– –
SPRO icon
32
Spero Therapeutics
SPRO
$68.3M
$1.19M 0.06%
889,979
– –
RAPT
33
DELISTED
RAPT Therapeutics
RAPT
$1.09M 0.06%
67,534
– –
HYPR icon
34
Hyperfine
HYPR
$95.3M
$971K 0.05%
898,720
– –
RANI icon
35
Rani Therapeutics
RANI
$91M
$969K 0.05%
448,492
– –
WGS icon
36
GeneDx Holdings
WGS
$1.8B
$964K 0.05%
+22,711
New +$767K
ALEC icon
37
Alector
ALEC
$168M
$820K 0.04%
175,866
– –
QNCX icon
38
Quince Therapeutics
QNCX
$17.5M
$148K 0.01%
946
– –
RGEN icon
39
Repligen
RGEN
$7.39B
$57K ﹤0.01%
383
– –
FULC icon
40
Fulcrum Therapeutics
FULC
$249M
$50.9K ﹤0.01%
14,262
– –
ILMN icon
41
Illumina
ILMN
$28.7B
– –
-53,470
Closed -$5.58M
HLTH
42
DELISTED
Cue Health Inc. Common Stock
HLTH
$0 ﹤0.01%
27,000
– –
NVTA
43
DELISTED
Invitae Corporation
NVTA
$0 ﹤0.01%
235,606
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2024 Portfolio in Review

As of Q3 2024, Alphabet Inc held 43 positions worth $1.84B, down 6.7% from $1.97B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Alphabet Inc withdrew a net $56M in Q3 2024, closing 1 position and reducing 3 holdings. Its most notable exit was Illumina, an estimated $5.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in GeneDx Holdings worth $964K.

  • Alphabet Inc's largest Q3 2024 buy was GeneDx Holdings: 22,711 shares worth $964K.
  • Alphabet Inc added most to Freshworks in Q3 2024, an estimated $46.4M increase.
  • Alphabet Inc's biggest Q3 2024 reduction was Snowflake, cutting an estimated $51.8M.
  • Alphabet Inc fully exited Illumina in Q3 2024, selling an estimated $5.58M.
  • Alphabet Inc's ten largest holdings make up 90% of its $1.84B portfolio in Q3 2024.
  • Alphabet Inc opened 1 new position and closed 1 in Q3 2024.
  • Alphabet Inc's portfolio value fell 6.7% quarter-over-quarter to $1.84B.

Based on Alphabet Inc's 13F filing for Q3 2024, filed 8 Nov 2024.